Connective tissue activating peptide III induction of synthesis and secretion of plasminogen activator by synovial fibroblasts
Open Access
- 1 June 1984
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 27 (6), 663-667
- https://doi.org/10.1002/art.1780270609
Abstract
Connective tissue activating peptide III (CTAP-III) is a platelet factor that induces, in cultured connective tissue cells, activities observed in chronic inflammation. In this study we measured plasminogen activator secretion by synovial fibroblasts after stimulation by CTAP-III. Increased plasminogen activator secretion was observed 24—48 hours after stimulation. Induction was prevented by dexamethasone (10-9—10-7M), cycloheximide (1 μg/ml) and, variably, by actinomycin D (0.3 μg/ml), but not by cytosine arabinoside (10-4M). This is the first evidence that CTAP-III induces degradative as well as proliferative activity by connective tissue cells.This publication has 30 references indexed in Scilit:
- Human synovial fibroblast plasminogen activator. modulation of enzyme activity by antiinflammatory steroidsArthritis & Rheumatism, 1981
- Connective tissue activationArthritis & Rheumatism, 1981
- Connective tissue activationArthritis & Rheumatism, 1979
- Platelets in the synovial spaceArthritis & Rheumatism, 1978
- Plates in synovial fluidArthritis & Rheumatism, 1978
- Endogenous Activation of Latent Collagenase by Rheumatoid Synovial CellsNew England Journal of Medicine, 1977
- Connective tissue activationArthritis & Rheumatism, 1977
- Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharidesImmunochemistry, 1976
- Macrophage plasminogen activator: Modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotidesCell, 1976
- Identification of a new platelet aggregating factor released by sensitized leukocytesClinical Immunology and Immunopathology, 1975